Advanced search
Publication Cover
Leukemia & Lymphoma Volume 47, 2006 - Issue 10
Submit an article Journal homepage
80
Views
9
CrossRef citations to date
0
Altmetric
Original

Results of a clinical phase I dose-escalation study of cytarabinein combination with fixed-dose vinorelbine, paclitaxel, etoposideand cisplatin for the treatment of relapsed/refractory lymphoma

Sagar Lonial Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USACorrespondence[email protected]
,
Martha Arellano Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA
,
Donald Hutcherson Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA
,
Amelia Langston Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA
,
Christopher Flowers Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA
,
L. T. Heffner Jr Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA
,
Elliott Winton Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA
,
Mary Jo Lechowicz Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA
&
Edmund K. Waller Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA
 show all
Pages 2155-2162 | Received 22 Dec 2005, Accepted 27 Apr 2006, Published online: 01 Jul 2009

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Rajni Sinha, Loretta J Nastoupil & Christopher R Flowers. (2012) Treatment strategies for patients with diffuse large B-cell lymphoma: past, present, and future. Blood and Lymphatic Cancer: Targets and Therapy 2, pages 87-98.
Read now
Disni Muringampurath-John, Christopher R. Flowers, Michael Toscano, Chen Zhengjia, Jonathan L. Kaufman, Martha Arellano, Leon Bernal-Mizrachi, Leonard T. Heffner, Mary-Jo Lechowicz, Morgan McLemore, Elliott Winton, David L. Jaye, Sagar Lonial & Hanna Jean Khoury. (2012) Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma. Leukemia & Lymphoma 53:4, pages 725-727.
Read now
Roni Glover, Pareen Jaideep Shenoy, Grishma A. Kharod, Allison Schaefer, Kevin Bumpers, Jamillah T. M. Berry & Christopher R. Flowers. (2011) Patterns of Social Support Among Lymphoma Patients Considering Stem Cell Transplantation. Social Work in Health Care 50:10, pages 815-827.
Read now

Articles from other publishers (6)

Marilia Barreca, Anastasios Stathis, Paola Barraja & Francesco Bertoni. (2020) An overview on anti-tubulin agents for the treatment of lymphoma patients. Pharmacology & Therapeutics 211, pages 107552.
Crossref
Loretta J. Nastoupil, Jean L. Koff, Leon Bernal-Mizrachi & Christopher R. Flowers. 2018. The American Cancer Society's Oncology in Practice. The American Cancer Society's Oncology in Practice 444 462 .
Rajni Sinha, Pareen J. Shenoy, Nassoma King, Mary Jo Lechowicz, Kevin Bumpers, Donald Hutcherson, Martha Arellano, Amelia Langston, Jonathan Kaufman, Leonard T. HeffnerJr.Jr., Edmund K. Waller, Ajay Nooka, Christopher R. Flowers & Sagar Lonial. (2013) Vinorelbine, Paclitaxel, Etoposide, Cisplatin, and Cytarabine (VTEPA) Is an Effective Second Salvage Therapy for Relapsed/Refractory Hodgkin Lymphoma. Clinical Lymphoma Myeloma and Leukemia 13:6, pages 657-663.
Crossref
Li Xu, Chunkang Chang, Xiao Li & Weijin Gan. (2009) Appropriate timing of G‐CSF use after mobilization chemotherapy significantly increases the yield of CD34+ cells in autoPBSCT. Journal of Clinical Apheresis 24:6, pages 232-237.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:3, pages 148-155.
Crossref
Michelle L. Hicks, Sagar Lonial, Amelia Langston, Christopher Flowers, John D. Roback, Kenneth J. Smith, Sarah Mossavi Sai, Diane Teagarden, Ellie S. Hamilton & Edmund K. Waller. (2007) Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells. Transfusion 47:4, pages 629-635.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.